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The fetal time period is a critical window of immune system development and resulting heightened
susceptibility to the adverse effects of environmental exposures. Epidemiologists and toxicologists have
hypothesized that phthalates, bisphenol A (BPA) and perﬂuoroalkyl substance have immunotoxic
properties. Immunotoxic effects of chemicals may manifest in an altered immune system proﬁle at birth.
Immunoglobulin E, thymic stromal lymphopoietin (TSLP), and interleukin-33 (IL-33) are integral in the
etiology of childhood allergy and detectable at birth. The objective of this study was to determine the
association between maternal levels of phthalates, bisphenol A (BPA), and perﬂuoroalkyl substances and
elevated umbilical cord blood levels of IgE, TSLP, and IL-33. This study utilized data collected in the
Maternal-Infant Research on Environmental Chemicals (MIREC) Study, a trans-Canada cohort study of
2001 pregnant women. Of these women, 1258 had a singleton, term birth and cord blood sample. A
Bayesian hierarchical model was employed to determine associations between log-transformed con-
tinuous variables and immune system biomarkers while adjusting for potential confounding from cor-
related environmental contaminants. Inverse, nonlinear associations were observed between maternal
urinary MCPP levels and elevated levels of both IL-33/TSLP and IgE and between maternal urinary BPA
levels and elevated levels of IL-33/TSLP. In this primarily urban Canadian population of pregnant women
and their newborns, maternal urinary and plasma concentrations of phthalate metabolites, BPA, and
perﬂuoroalkyl substances were not associated with immunotoxic effects that manifest as increased odds
of elevated levels of IgE, TSLP or IL-33.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction1
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iﬁcation systems (Barr et al., 2007). Exposure to environmental
contaminants during this time can promote permanent, irrever-
sible changes to immune system development and increase risk of
an allergic phenotype (Holladay and Smialowicz, 2000; Martino
and Prescott, 2011). Exploration of in utero exposures that may
precipitate these changes is, therefore, critical to understanding
the etiology of childhood allergic disease (Prescott and Clifton,
2009).
Epidemiologists and toxicologists have hypothesized that
phthalates (Bornehag and Nanberg, 2010; Kimber and Dearman,
2010), bisphenol A (BPA) (Midoro-Horiuti et al., 2009) and per-
ﬂuoroalkyl substances (Dewitt et al., 2012; Fletcher et al., 2009)
may have immunotoxic properties. These contaminants are ubi-
quitous in the environment; the majority of adults have detectable
concentrations in their urine or plasma (NHANES, 2013; Sar-
avanabhavan et al., 2013; Health Canada, 2013). Moreover, ma-
ternal urinary or plasma concentrations of phthalates, BPA, and
perﬂuoroalkyl substances results in fetal exposure as these con-
taminants are known to cross the placenta (Mørck et al., 2010; US
DHHS, 1995; Li et al., 2013).
Despite the ubiquity of these contaminants and potential for
immunotoxic effects, the epidemiologic literature regarding the
association between prenatal exposure to these contaminants and
childhood allergic diagnoses is limited. Moreover, validity of stu-
dies that examine childhood allergic diagnosis is challenged by:
(1) confounding from childhood exposures to allergy risk factors
and (2) outcome misclassiﬁcation inherent in the diagnosis of
childhood allergic disease (Ballmer-Weber, 2014; Lipozencić and
Wolf, 2010; Reed, 2006).
The immunotoxic effects of in utero environmental con-
taminant exposure may manifest in altered levels of immune
system biomarkers at birth. An altered immune system proﬁle at
birth is a risk factor for childhood allergy (Dietert, 2009; Martino
and Prescott, 2011; Warner, 2004). The immune system bio-
markers, immunoglobulin E (IgE), interleukin-33 (IL-33) and thy-
mic stromal lymphopoietin (TSLP), are detectable in cord blood
(Ashley-Martin et al., 2015). Elevated levels are associated with
inﬂammatory processes and allergic disease in later life (Bartemes
and Kita, 2012; Lambrecht and Hammad, 2013). Cord blood IgE
levels have been previously used as a means of assessing the im-
munotoxic effects of in utero environmental contaminant ex-
posure (Herr et al., 2011; Okada et al., 2012; Wang et al., 2011).
TSLP and IL-33 have recently been recognized for their etiologic
role in atopic dermatitis, the earliest manifestation of childhood
allergy (Brandt and Sivaprasad, 2011; Lee et al., 2010). Unlike other
cytokines that are produced from hematopoietic cells (Abbas et al.,
2013), epithelial cell production of TSLP and IL-33 is not depen-
dent on the presence of a functioning, developed immune system
function (Oliphant et al., 2011). Analysis of TSLP and IL-33 levels in
cord blood provides a novel means for examining the suscept-
ibility of the newborn immune system to the potential adverse
effects of in utero exposure to environmental contaminants.
The objective of this study was to determine the association
between maternal levels of phthalates, bisphenol A (BPA), and
perﬂuoroalkyl substances and elevated umbilical cord blood levels
of IgE, TSLP, and IL-33 in Canadian birth cohort. A secondary ob-
jective was to determine how relationships may differ by infant
sex. Due to the co-occurrence of phthalate metabolites within
common household products (e.g. cosmetics, plastics), individuals
are routinely exposed to multiple phthalate metabolites simulta-
neously (Dodson et al., 2012). The concentrations of multiple
perﬂuoroalkyl substances in household dust have been shown to
be correlated (D’Hollander et al., 2010). We employed an analytical
approach to account for the potential effects of correlated
exposures.2. Materials and methods
2.1. Study population and data sources
This study used data and biospecimens from the Maternal-In-
fant Research on Environmental Chemicals (MIREC) Study Bio-
bank, a trans-Canada cohort study of 2001 pregnant women from
10 Canadian cities recruited during 2008–2011 (Arbuckle et al.,
2013). The target population was pregnant women and their
newborns who reside in these 10 urban regions and surrounding
catchment areas. Approximately 6% of study participants live in a
rural area according to postal forward sortation area. Study par-
ticipants were contacted throughout pregnancy at pre-speciﬁed
time points to obtain data and biospecimens. Brieﬂy, women were
eligible for inclusion if they were o14 weeks gestation at time of
recruitment, Z18 years of age, able to communicate in French or
English, and planning on delivering at a local hospital (Arbuckle
et al., 2013). The population in the present investigation was
mothers who had a singleton, live, term birth (Z37 weeks) and a
cord blood sample suitable for analysis. Cord blood samples (n¼5)
that were determined to be contaminated with maternal blood
based on an elevated immunoglobulin A (IgA) level (Z 10 mg/mL)
were excluded from the analysis (Ownby et al., 1996). A compar-
ison of the full cohort with chemical data and the analytical
sample demonstrated no notable differences in age, smoking or
chemical concentrations between the two groups. Mean birth
weight (g) was higher in the analytical sample (mean (SD) ¼3530
(454)) compared to the whole cohort (mean (SD) ¼3433.2
(583.5)). As the analytical sample did not include preterm or
multiple births, this difference is expected. This study received
ethical approval from Health Canada, St. Justine's Hospital (Mon-
treal, QC), and the IWK Health Centre (Halifax, NS) and all parti-
cipants signed informed consent forms.
2.2. Environmental contaminant exposure
BPA and 11 phthalate metabolites were measured in maternal
urine collected during the 1st trimester as shown in Table 1 and as
previously described (Arbuckle et al., 2014). Brieﬂy, chemical
analysis of urine samples was carried out at the Laboratoire de
Toxicologie, Institut National de Santé Publique du Québec (Qué-
bec, QC, Canada), accredited by the Standards Council of Canada.
Phthalates in urine were analyzed by LC–MS/MS with an Ultra
Performance Liquid Chromatography (UPLC) coupled with a
Quattro Premier XE tandem mass spectrometer following enzy-
matic deconjugation. Total BPA in urine were measured with a GC
Agilent 6890 N GC–MS–MS instrument (Agilent Technologies;
Mississauga, ON, Canada) coupled with a Quattro Micro GC tan-
dem mass spectrometer (Waters; Milford, Massachusetts, USA). An
enzymatic hydrolysis freed the conjugated compounds in the ur-
ine, the samples were then derivatized and the derivatives ex-
tracted and analyzed. Perﬂuoroalkyl substances were measured in
study participant 1st trimester plasma using a Water Acquity
UPLC–MS–MS operated in the MRM mode with an electrospray
ion source in negative mode.
2.3. Fetal markers of immune system function
Immune system biomarkers were measured in the plasma of
umbilical cord blood samples in the Department of Microbiology &
Immunology, Dalhousie University, Halifax, NS using ELISA. TSLP
concentrations were determined using a commercial antibody kit
(Biolegend; San Diego, CA, USA). IL-33 concentrations were as-
sessed using antibodies from an R & D systems duoset (Minnea-
polis, MN, USA). ELISA kits (EBioscience; San Diego, CA, USA) were
also used to assess both total IgE and IgA concentrations. ELISA
Table 1
Geometric mean of environmental contaminants (mg/L) by categories of TSLP, IL-33, and IgE (MIREC study, 2008–2011).
IL-33/TSLP (pg/mL) IgE (ku/L)
Chemical (μg/L) LOD (lg/L) % 4LOD Z 80% o 80% Z 0.5 ku/L o0.5 ku/L
GM (SD) GM (SD) GM (SD) GM (SD)
Phthalate metabolites & BPA (n¼1137)a
Mono-ethyl phthalate (MEP) 0.5 99.8 33.9 (3.9) 39.0 (4.1) 32.4 (3.8) 39.3 (4.1)
Mono-n-butyl phthalate (MBP) 0.2 99.7 12.6 (2.5) 13.3 (2.3) 12.9 (2.4) 13.2 (2.3)
Mono-benzyl phthalate (MBzP) 0.2 99.5 5.5 (2.8) 6.0 (2.7) 6.4 (3.0) 5.9 (2.6)
Mono-3-carboxyypropyl phthalate (MCPP) 0.2 83.9 0.9 (2.6) 1.0 (3.0) 0.9 (2.7) 1.0 (3.0)
Mono-2-ethylhexyl phthalate (MEHP) 0.2 98.3 2.5 (2.6) 2.7 (2.5) 2.6 (2.7) 2.6 (2.5)
Mono-(2-ethyl-5-hydroxyhexyl) (MEHHP) 0.4 99.3 9.4 (2.6) 10.7 (2.5) 10.4 (2.7) 10.6 (2.4)
Mono-(2-ethyl-5-oxohexyl) (MEOHP) 0.2 99.7 6.8 (2.5) 7.5 (2.3) 7.4 (2.5) 7.4 (2.3)
Bisphenol A (BPA) 0.2 86.6 0.9 (2.6) 0.9 (2.8) 0.9 (2.6) 0.9 (2.8)
Mono cyclohexyl phthalate (MCHP) 0.2 7.4
Mono-n-octyl phthalate (MOP) 0.6 3.0
Mono-isononyl phthalate (MNP) 0.4 1.1
Mono-methyl phthalate (MMP) 5 14.0
Perﬂuoroalkyl substances (n¼1242)
Perﬂuorooctanoic acid (PFOA) 0.3 99.8 1.7 (1.9) 1.7 (1.8) 1.7 (1.9) 1.6 (1.8)
Perﬂuorooctane sulfonate (PFOS) 0.1 99.8 4.7 (1.9) 4.5 (1.8) 4.6 (1.9) 4.6 (1.8)
Perﬂuorohexane sulfanoate (PFHxS) 0.3 96.0 1.0 (2.2) 1.0 (2.3) 1.0 (2.4) 1.0 (2.3)
a Geometric means and standard deviations are adjusted for speciﬁc gravity; LOD¼ limit of detection, GM¼geometric mean, SD¼standard deviation.
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with the exception that plates were coated with sodium bicarbo-
nate buffer (pH 8.3–8.5) and blocked with 2% BSA in PBS instead of
using the manufactures coating and blocking buffers. The inter-
assay and intra-assay CVs for IL-33 were 5.9% and 11.3% respec-
tively; for TSLP inter and intra-assay CVs were 6.0% and 8.1% re-
spectively. The inter-assay and intra-assay CVs were 3.2% and 6.5%
respectively for IgE and 5.2% and 10.4% respectively for IgA. These
coefﬁcients of variation were determined empirically in our study
using the standard curves and sample controls on each ELISA
plate.
2.4. Statistical analysis
Due to the high percentage of samples below the limit of de-
tection (LOD), each immune system biomarker was categorized as
a binary variable. A composite variable was developed to identify
samples with elevated concentrations of both TSLP and IL-33 (IL-
33/TSLP) as these cytokines are highly correlated (Spearman cor-
relation coefﬁcient¼0.8). TSLP and IL-33 were categorized at the
80th percentile (TSLP¼554 pg/mL; IL-33¼879 pg/mL) because
there are no pre-existing thresholds. Elevated concentrations of
the composite IL-33/TSLP variable were deﬁned as those samples
that had elevated concentrations (Z80%ile) of both TSLP and IL-
33. The cut-off percentile for IgE was deﬁned at 1.2 ng/mL (0.5 kU/
L), a cut-off point previously used in studies of cord blood IgE
(Pesonen et al., 2009; Sadeghnejad et al., 2004).
Maternal urinary measures of 11 phthalate metabolites and BPA
collected from a spot urine sample in the 1st trimester were available
in the MIREC study (Table 1). Four phthalate metabolites (MCHP,
MOP, MNP, MMP) were not examined in multivariate analysis due to
the low proportion of values above the limit of detection (% 4LOD
MCHP¼7.4, MOP¼3.0, MNP¼1.1, MMP¼14.0). Three of the phtha-
late metabolites are primary (MEHP) and secondary (MEHHP,
MEOHP) metabolites of the parent compound Di(2-ethylhexyl)
phthalate (DEHP) (Hauser and Calafat, 2005). Considering the high
correlation (Pearson correlation coefﬁcient¼0.9) between these
metabolites, they were not analyzed as individual metabolites.
Rather, metabolite concentrations were summed to create an index
of DEHP metabolite exposure as previously reported (Hoppin et al.,
2013). Maternal measures of three perﬂuoroalkyl substances werecollected from 1st trimester plasma (Table 2). All values less than the
LOD were substituted as LOD/2.
As the distribution of the environmental contaminants was
non-normal, chemical concentrations were log-transformed to
calculate descriptive statistics and perform multivariate analysis.
Geometric means and standard deviations were calculated for the
all environmental contaminants according to high and low levels
of the immune system biomarkers. Concentrations of phthalate
metabolites and bisphenol A were adjusted for urinary speciﬁc
gravity according to the following formula Pc¼Pi [(SGm1)/
(SGi1)] where: Pc¼SG adjusted metabolite concentration (mg/
ml), Pi ¼observed metabolite concentration, SGi ¼speciﬁc gravity
of the urine sample, and SGm¼median SG for the cohort (Just
et al., 2010).
As the distribution of the environmental contaminants was
normal upon log-transformation, the Pearson correlation coefﬁ-
cient was used to examine correlation among the chemicals. The
Pearson correlation coefﬁcients of log-transformed phthalate
metabolites and bisphenol A ranged from 0.3 (between MEP and
BPA) to 0.6 (between MBP and DEHP metabolites). The correlation
coefﬁcients of the log-transformed perﬂuoroalkyl substances
ranged from 0.5 (between PFOA and PFHxS) to 0.6 (between PFOA
and PFOS). Bayesian hierarchical logistic regression models were,
therefore, employed to estimate odds ratios (OR) and 95% credible
intervals (CI) for the association between the environmental con-
taminants and immune system biomarkers. The outcome variables
were elevated IL-33/TSLP and elevated IgE (as deﬁned above). This
approach facilitates inclusion of correlated exposures and is not
subject to the challenges of convergence and unstable estimates
faced by maximum likelihood regression models (Maclehose et al.,
2007). A separate hierarchical model was developed for each
chemical class (e.g. phthalates,perﬂuoroalkyl substances) and
outcome (IL-33/TSLP and IgE). As the correlation between BPA and
phthalate metabolites was comparable to the within-phthalate
correlation (e.g. MBP–BPA correlation coefﬁcient¼0.5), BPA was
included in the phthalate model.
The Bayesian model was run with three chains and 5000
iterations with the ﬁrst 500 iterations discarded as a burn-in
period. The prior distribution for the parameter estimates of the
exposure variables was modeled as a normal distribution (0, Φ)
where Φ was modeled as a half-normal distribution (mean¼0,
Table 2
Maternal demographic characteristics, MIREC Study, Canada, 2008–2011
(n¼1258).a
Characteristic N (%)
Maternal demographic
Maternal age (yr)
r24 60 (4.8)
25–29 270 (21.5)
30–34 452 (35.9)
Z35 476 (37.8)
Household Income ($CAD)
r30,000 90 (7.4)
30,001–50,000 117 (9.7)
50,001–100,000 515 (42.6)
4100,000 487 (40.3)
Parental smokingb
No 1008 (80.1)
Yes 249 (19.9)
Pet ownership
No 560 (44.5)
Yes 698 (55.5)
Maternal reproductive & medical history
Pre-pregnancy BMIc
Underweight (o18.5) 27 (2.3)
Normal (18.5–24.9) 718 (60.4)
Overweight (25 –29.9) 272 (22.9)
Obese (Z30) 171 (14.4)
Maternal allergyd
No 1204 (95.7)
Yes 54 (4.3)
Parity
Nulliparous 526 (41.9)
Primiparous 512 (40.8)
Multiparous 217 (17.3)
Infant characteristics
Infant sex
Male 672 (53.5)
Female 585 (46.5)
Birth weight (g)
o2500 11 (0.9)
2500–o3500 606 (48.2)
3500–o4000 449 (35.7)
Z4000 192 (15.3)
a Subgroup total may not equal 1258 due to missing data.
b Deﬁned as either the mother or father smoking during pregnancy.
c World Health Organization Classiﬁcation (WHO, 2000).
d Deﬁned as use of maternal allergy medication.
Fig. 1. Restricted cubic spline curve of association between maternal urinary log10
MCPP concentrations and high IL-33/TSLP cord blood concentrations (MIREC study,
2008–2011). nAdjusted for maternal age, speciﬁc gravity. Dotted lines represent 95%
conﬁdence interval, dots represent knots deﬁned at the 5th, 50th, and 95th
percentiles.
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prior distribution was chosen to reﬂect lack of prior knowledge
regarding the association between these chemicals and newborn
immune system development. The distribution is uninformative
due to the large variance. In comparison to models that apply a
ﬁxed variance and resulting ﬁxed degree of estimate shrinkage
toward the prior mean, this approach allows the degree of
shrinkage to vary depending on how closely the data ﬁt the prior
distribution (Maclehose et al., 2007). Model convergence was
assessed by visual assessment of trace plots and by conver-
gence diagnostic tests (Gelman–Rubin convergence test o1.05;
R-hat¼1)(Yau, 2014). Details on the model are provided in
Appendix A (available in Supplementary material).
Prior to inclusion in the hierarchical models, the linearity of
each contaminant-immune system biomarker association was as-
sessed using restricted cubic spline models (Desquilbet and Mar-
iotti, 2010). Knots were set at the 5th, 50th, and 95th percentiles.
Environmental contaminants that met the criteria for linearity
were log-transformed and those that did not were modeled with aquadratic term.
Potential covariates were identiﬁed using a causal model
(Greenland et al., 1999). The causal models were constructed using
evidence regarding predictors of the exposures (Arbuckle et al.,
2014; Kudo and Kawashima, 2003) and predictors of the immune
system biomarkers (Ashley-Martin et al., 2015; Scirica et al., 2007).
The minimal adjustment sets for confounding were identiﬁed
using DAGitty (Textor and Hardt, 2011). Speciﬁc gravity was forced
into the adjusted phthalate/BPA model to account for hetero-
geneity in urinary dilution (Arbuckle et al., 2014). As childhood
allergy prevalence differs by sex (Kynyk et al., 2011), analyses were
also stratiﬁed by sex.
Descriptive statistics were performed in SAS V.9.2 (Cary, NC).
Bayesian modeling was performed using R v.3.0.3 (The R Foun-
dation for Statistical Computing) and Openbugs (v 3.2.1 Members
of OpenBUGS Project Management Group).3. Results
Of the 2001 women recruited, 18 withdrew and asked that all
their data and biospecimens be destroyed. Of the remaining 1983
subjects, 1363 women had a cord blood sample. Of these 1363
samples, a total of 105 samples were excluded for a high IgA
concentration, pre-term birth (o 37 weeks), multiple birth, or
samples with insufﬁcient sample for analysis, and no chemical
data for either phthalates, BPA and the perﬂuoroalkyl substances
leaving 1258 subjects for inclusion in the statistical analysis. An
additional 121 women did not have maternal urinary measure-
ments of phthalates and an additional 16 women did not have
maternal plasma measurements of perﬂuoroalkyl substances.
Table 1 depicts geometric mean ﬁrst trimester concentrations of
phthalates and perﬂuoroalkyl substances according to categories of
the immune system biomarkers. Maternal demographic, reproductive,
and infant characteristics are depicted in Table 2. The majority of study
participants were greater than 30 years of age, had a household in-
come greater than $50,000, were non-smokers, and of normal BMI.
Signiﬁcant non-linear associations were observed between the
Fig. 2. Restricted cubic spline curve of association between maternal urinary log10
MCPP urinary concentrations and high IgE cord blood levels (MIREC study, 2008–
2011). nAdjusted for maternal age, speciﬁc gravity. Dotted lines represent 95%
conﬁdence interval, dots represent knots deﬁned at the 5th, 50th, and 95th
percentiles.
Fig. 3. Restricted cubic spline curve of association between maternal urinary log10
BPA concentrations and high IL-33/TSLP cord blood concentrations (MIREC study,
2008–2011). nAdjusted for maternal age, speciﬁc gravity. Dotted lines represent 95%
conﬁdence interval, dots represent knots deﬁned at the 5th, 50th, and 95th
percentiles.
Table 3
Bayesian odds ratios of elevated (Z80%) cord blood IL-33/TSLP (pg/mL) and ma-
ternal concentrations of log10 environmental contaminants (mg/L) (MIREC study,
2008–2011).
Contaminant Unadjusted OR (95% CI) Adjusted ORa (95% CI)
Phthalates & BPAa (n¼1137)
MEP 0.9 (0.7–1.1) 0.9 (0.7–1.1)
MBP 1.0 (0.6–1.4) 1.0 (0.7–1.4)
MBzP 1.0 (0.7–1.3) 0.9 (0.7–1.3)
MCPP 0.9 (0.7–1.2) 0.9 (0.7–1.2)
MCPPnMCPP 0.8 (0.5–1.0) 0.8 (0.5–1.1)
∑ DEHP 0.9 (0.6–1.2) 0.9 (0.7–1.3)
BPA 1.0 (0.7–1.3) 1.0 (0.7–1.3)
BPAnBPA 0.8 (0.5–1.0) 0.8 (0.5–1.0)
Perﬂuoroalkyl substancesb (n¼1242)
PFOA 1.1 (0.6–1.9) 1.1 (0.6–1.8)
PFOS 1.1 (0.6–1.9) 1.1 (0.6–1.9)
PFHxS 1.0 (0.7–1.4) 1.0 (0.7–1.4)
a Adjusted for maternal age, speciﬁc gravity.
b Adjusted for maternal age, sex.
Table 4
Bayesian odds ratio of elevated (Z0.5 ku/L) cord blood IgE (ku/L) and maternal
concentrations of log10 environmental contaminants (mg/L) (MIREC study, 2008–
2011).
Contaminant Unadjusted OR (95% CI) Adjusted OR (95% CI)
Phthalates & BPAa (n¼1137)
MEP 0.8 (0.6–1.0) 0.8 (0.6–1.0)
MBP 1.0 (0.6–1.4) 0.9 (0.6–1.3)
MBzP 1.3 (0.9–1.8) 1.2 (0.9–1.7)
MCPP 0.8 (0.6–1.1) 0.8 (0.6–1.1)
MCPPnMCPP 0.7 (0.5–1.0) 0.7 (0.5–1.0)
∑ DEHP 1.0 (0.7–1.4) 1.0 (0.7–1.5)
BPA 1.0 (0.8–1.4) 1.0 (0.7–1.3)
Perﬂuoroalkyl substanceb (n¼1242)
PFOA 1.1 (0.6–2.0) 1.1 (0.6–1.9)
PFOS 1.1 (0.6–2.0) 1.1 (0.6–1.9)
PFHxS 1.0 (0.7–1.4) 1.0 (0.7–1.4)
a Adjusted for maternal age, speciﬁc gravity.
b Adjusted for maternal age, sex.
J. Ashley-Martin et al. / Environmental Research 140 (2015) 360–368364phthalate metabolite MCPP (P-value¼0.008 test for linearity; P-
value ¼0.01 test for association) and BPA (P-value test for linear-
ity¼0.02, P-value test for association 0.05) and odds of elevated
IL-33/TSLP (Figs. 1–2). MCPP was also observed to have a sig-
niﬁcant, non-linear association with odds of elevated IgE (P-value
linearity¼0.01, P-value association¼0.02) (Fig. 3). Thus, quadratic
terms for both MCPP and BPA were included in the IL-33/TSLP
model and a quadratic term for MCPP was included in the IgE
model. There were no signiﬁcant non-linear associations betweenthe perﬂuoroalkyl substances and either IL-33/TSLP or IgE.
Tables 3 and 4 depict results of the Bayesian hierarchical
models. The quadratic term for maternal urinary BPA concentra-
tions was inversely associated with odds of elevated IL-33/TSLP
(aOR¼0.8; 95% CI: 0.5–1.0) (Table 3). The quadratic term for MCPP
was inversely associated with odds of elevated IgE (aOR¼0.7; 95%
CI: 0.5–1.0) (Table 5). Credible intervals for all other phthalates and
perﬂuoroalkyl substances included the null value (Tables 3 and 4).
Results were similar among male and female infants in all statis-
tical models (Supplementary Tables 1–4).4. Discussion
In this study, we sought to determine the association between
ﬁrst trimester maternal levels of phthalates, BPA, and per-
ﬂuoroalkyl substances and elevated umbilical cord blood levels of
IgE, TSLP and IL-33. This question was motivated by the fact that in
utero environmental contaminant exposure may alter newborn
immune system development and promote risk of an allergic
phenotype (Luebke et al., 2006; Martino and Prescott, 2011).
Consistent with the inverted U-shaped curve observed in the re-
stricted cubic spline analyses, we found an inverse, non-linear
association between maternal urinary MCPP levels and elevated
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J. Ashley-Martin et al. / Environmental Research 140 (2015) 360–368 365levels of both IL-33/TSLP and IgE in the Bayesian hierarchical
model. An inverse, non-linear association was also observed be-
tween maternal urinary BPA levels and elevated levels of IL-33/
TSLP in the Bayesian hierarchical model, similarly consistent with
the association observed in the restricted cubic spline analysis.
These ﬁndings suggest that traditional monotonic assumptions
regarding dose–response relationships may not be an appropriate
characterization of endocrine disruptor related health effects.
Clinical interpretation of the observed non-linear relationships
requires evaluation in a cohort of children with allergic disease
data. We did not observe any associations between the con-
taminants of interest and elevated levels of IgE, or IL-33/TSLP
where the credible interval did not include the null.
4.1. Prenatal exposure to phthalate metabolites and measures of
childhood allergy
The potential role of phthalate exposure in childhood allergy
etiology is supported by experimental evidence demonstrating
that these chemicals exhibit adjuvant-like properties (Kimber and
Dearman, 2010). Epidemiological evidence regarding prenatal
phthalate exposure is, however, equivocal. To our knowledge, au-
thors of two birth cohort studies in New York (Just et al., 2012;
Whyatt et al., 2014) and Taiwan (Wang et al., 2014) have examined
the association between prenatal urinary phthalate exposure
measurements and measures of childhood allergy. One recent
cohort study examined the association between a proxy measure
of exposure and childhood allergy (Shu et al., 2014). The Taiwanese
birth cohort reported no statistically signiﬁcant associations be-
tween phthalate metabolites and cord blood IgE (Wang et al.,
2014). Investigators of the New York city cohort reported a sig-
niﬁcant association between maternal urinary phthalate metabo-
lite (MBzP) concentrations and eczema at two but not ﬁve years of
age (Just et al., 2012). In a later follow-up of this cohort, authors
report a signiﬁcant association between prenatal MBzP exposure
and childhood asthma diagnosed between the ages of 5 and 11
(Whyatt et al., 2014). Considering that the present study also
identiﬁed a slight positive association between cord blood IgE le-
vels and MBzP exposure (OR¼1.2 95% CI: 0.9–1.7), further in-
vestigation into the role of this metabolite in childhood allergy
etiology is warranted. Divergence in other results among the New
York (Just et al., 2012), Taiwanese (Wang et al., 2014) and present
study may be explained by the heterogeneity in target popula-
tions, exposure levels, or outcome measures (Table 5). The differ-
ent units of measurement in MIREC (mg/L) and the Taiwanese
study (mg/g creatinine) preclude direct comparison of exposure
levels. Median levels in the MIREC study were, however, lower
than those reported in the New York cohort. This difference may
be one explanation for the lack of observed effect in the present
study. Authors of the Dampness in Buildings and Health study in
Sweden reported that the presence of polyvinyl chloride ﬂooring
in children's homes at age 1–5 years was associated with a two-
fold increased risk of self-reported childhood asthma after 10
years of follow-up (Shu et al., 2014). The lack of direct phthalate
metabolite measurements in this study precludes comparison of
exposure levels with other birth cohort studies.
4.2. Prenatal exposure to BPA and measures of childhood allergy
Experimental evidence has demonstrated that BPA may induce
an asthmatic pshenotype by elevating IgE levels and promoting
eosinophilic inﬂammation (Midoro-Horiuti et al., 2009; Nakajima
et al., 2012). However, epidemiological literature regarding pre-
natal BPA exposure and childhood allergy is limited and incon-
sistent. A birth cohort study from the mid-west US (Spanier et al.,
2012) reported a positive association between maternal urinary
J. Ashley-Martin et al. / Environmental Research 140 (2015) 360–368366BPA levels and childhood wheeze whereas the NY birth cohort
investigators (Donohue et al., 2013) reported an inverse associa-
tion. In contrast, in the present study we identiﬁed a non-
linear association between BPA and elevated IgE. In addition to
differences outlined in Table 5, a possible explanation for the
heterogeneity in results is exposure misclassiﬁcation. The short
half-life (Stahlhut et al., 2009), complexity of metabolism
(Zalko et al., 2003), and potential contamination of urinary sam-
ples with external sources of BPA (e.g. laboratory equipment) (Ye
et al., 2013) create material challenges to accurately estimating
fetal BPA levels.
4.3. Prenatal exposure to perﬂuoroalkyl substances and measures of
childhood allergy
In experimental models, perﬂuorinated compounds have been
shown to induce immune system proﬁle changes indicative of an
allergic phenotype (Dewitt et al., 2012; Fairley et al., 2007). Two
previous birth cohort studies reported that the association be-
tween gestational perﬂuorinated compound exposure and cord
blood IgE levels differed by infant sex (Table 5) (Okada et al., 2012;
Wang et al., 2011). These ﬁndings may be explained by the fact
that PFOA has a longer half-live and slower renal clearance in
males (Kudo and Kawashima, 2003). The lack of notable differ-
ences by sex in the PFOA and IgE model in the present study may
be due to the relatively low percentage of cord blood samples with
levels of IgE above 0.5 ku/L.
4.4. Strengths and limitations
This study beneﬁted from the relatively large sample size in the
MIREC study, the comparatively rich covariate data, and the use of
novel immune system biomarkers. The study population was
predominantly from urban regions in Canada. We employed ana-
lytical methods to control for correlated exposures (Maclehose
et al., 2007) and assess non-linear associations. Furthermore, by
shrinking effect estimates towards each other, Bayesian hier-
archical models lower the likelihood of identifying a signiﬁcant
association by chance (Gelman et al., 2004).
This study was subject to at least ﬁve limitations common to
observational studies. First, the short half life and rapid elimina-
tion of phthalates and BPA creates a source of potential mis-
classiﬁcation bias as the body burden of these chemicals may vary
on a daily basis (Braun et al., 2011; Ye et al., 2011; Stahlhut et al.,
2009; Volkel et al., 2002). In pregnant women, the reported in-
traclass correlation (ICCs) for serial measurements of BPA
throughout pregnancy has been very low, ranging from 0.11 to
0.32 ([Braun et al., 2011,Meeker et al., 2014,Quirós-Alcalá et al.,
2013,Jusko et al., 2014]). A Canadian study of pregnant women
reported an ICC of 0.33 for BPA based on ﬁrst trimester 24 h urine
voids (Fisher et al., 2014). Given the similarities in timing of
measurement and study population, this value may be re-
presentative of the variability in MIREC measurements. The
phthalate metabolite MCPP was reported to have considerable
within person variability based on an ICC of 0.20 in a study of
serial measurements in pregnant women (Cantonwine et al.,
2014). Considering, however, that (1) that exposure misclassiﬁca-
tion is non-differential and (2) this study employed continuous
rather than polytomous exposure variables, any potential mis-
classiﬁcation bias likely attenuated effect estimates towards the
null (Rothman et al. 2008; Wacholder, 1995). Reproduction of the
present ﬁndings in cohort studies with serial phthalate and BPA
measurements would be valuable in investigating the inﬂuence of
this potential information bias. As our ﬁndings pertain to ﬁrst
trimester phthalate and BPA exposure only, reproduction in cohort
studies with serial measurements would also be valuable inascertaining the role of exposure during other trimesters. Due to
their longer half-life, perﬂuoroalkyl acids are not subject to the
degree of variability observed with the phthalates and BPA. First
and second trimester maternal PFOA levels have been shown to be
highly correlated (r¼0.9) (Fei et al., 2007), suggesting that ﬁrst
trimester exposure levels may be indicative of exposure through-
out pregnancy. Second, the MIREC study population was of higher
income and more educated than the target population. This po-
tential selection bias is unlikely to have biased the observed as-
sociations because the associations did not seem to be confounded
by income or education. The socioeconomic characteristics of the
MIREC population did, however, preclude our ability to assess
associations among certain population subgroups including low
income women with minimal secondary education. Third, the in-
ﬂuence of residual confounding cannot be ruled out. We did not
have information on certain risk factors for childhood allergy such
as vitamin D (Muehleisen and Gallo, 2013) and maternal stress
(Von Hertzen, 2002). Considering that an association between
these variables and exposure to the contaminants of interest is not
well established, it is unlikely that our observed associations are
invalidated by lack of control for these variables. Fourth, the po-
tential for non-differential misclassiﬁcation of the immune system
biomarkers exists. However, since within-person variability pri-
marily occurs longitudinally (Rothers et al., 2011) rather than at
birth, the extent of type 2 error resulting from this potential
misclassiﬁcation is thought to be minimal. Last, though the
Bayesian hierarchical model facilitated analysis of correlated ex-
posures, this model does not provide estimates of the potential
health related effects of exposure mixtures or potential synergistic
or antagonistic effects among chemicals.
4.5. Public health interpretations
Due to the lack of Canadian health-based biomonitoring
guidelines for the contaminants of interest, interpretation of the
present ﬁndings within a public health context is a challenge. On
average, the phthalate and BPA exposure levels observed within
the MIREC study are lower than other birth cohorts discussed
(Table 5) and consistent with the temporal trend of declining body
burden levels of many phthalates and BPA (NHANES, 2013; Zota
et al., 2014). Health Canada recently took regulatory action to
minimize exposure levels of BPA and certain phthalates to children
(Health Canada, 2010, 2011). Though these actions are unlikely to
directly affect prenatal exposure levels in the current study, the
regulations may promote heightened consumer awareness and
subsequent attempts to minimize use of BPA and phthalate-laden
products.
Plasma concentrations of PFOA and PFOS have also been de-
creasing over time, but concentrations of other perﬂuoroalkyl
substances (e.g. perﬂuorononanoic acid (PFNA)) have been on the
rise (Glynn et al., 2012; NHANES, 2013; Okada et al., 2013). The
decrease in PFOA and PFOS concentrations is explained by the
cessation of PFOA and PFOS production within the last 10 years
(Prevedouros et al., 2006; Health Canada, 2007). The persistent
nature and long half-life of these compounds (Kudo and Kawa-
shima, 2003) explains the continued presence of detectable con-
centrations of these chemicals in maternal plasma. The second
cycle of the Canadian Health Measures Study reported that the
majority of Canadians have detectable concentrations of some of
these less common compounds such as PFNA (Health Canada,
2013). As such, continuing biomonitoring efforts could help to
determine trends in levels and sources of exposure as well as in-
vestigate potential health effects.
The novel ﬁnding of a non-linear association between ﬁrst
trimester measures of MCPP and BPA and the immune system
biomarkers of interest in this study is consistent with evidence
J. Ashley-Martin et al. / Environmental Research 140 (2015) 360–368 367that endocrine disrupting chemicals may operate in a non-
monotonic manner (Vandenberg et al., 2012). Further elucidation
of these dose–response relationships and underlying biological
mechanisms will be a valuable contribution to the development of
health based biomonitoring guidelines for these contaminants.Acknowledgments
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